Kourtney Davis
- Characteristics of patients newly prescribed a long acting bronchodilator in the USBy Keele Wurst, Samantha St. Laurent, Hana Muellerova and Kourtney DavisKeele Wurst1Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, NC, United StatesSamantha St. Laurent1Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, NC, United StatesHana Muellerova2Worldwide Epidemiology, GlaxoSmithKline, Uxbridge, Middlesex, United KingdomKourtney Davis2Worldwide Epidemiology, GlaxoSmithKline, Uxbridge, Middlesex, United Kingdom
- A new user cohort study comparing the risk of pneumonia in inhaled corticosteroid (ICS) vs. long-acting bronchodilator (LABD) regimens in COPDBy Rachael DiSantostefano, Tim Sampson, Hoa Van Le, Kourtney Davis and Nawar BakerlyRachael DiSantostefano1Worldwide Epidemiology, GlaxoSmithKline, RTP, NC, United StatesTim Sampson1Worldwide Epidemiology, GlaxoSmithKline, RTP, NC, United StatesHoa Van Le1Worldwide Epidemiology, GlaxoSmithKline, RTP, NC, United StatesKourtney Davis1Worldwide Epidemiology, GlaxoSmithKline, RTP, NC, United StatesNawar Bakerly2Medicine, Salford Royal NHS Foundation Trust and Manchester University, Manchester, United Kingdom
- Characteristics and outcomes of GOLD C and D COPD patientsBy Hana Müllerová, MeiLan Han, Richard Baxter and Kourtney DavisHana Müllerová1Respiratory Epidemiology, GlaxoSmithKline RD, Uxbridge, Middlesex, United KingdomMeiLan Han2Division of Pulmonary and Critical Care, University of Michigan, Ann Arbor, MI,Richard Baxter1Respiratory Epidemiology, GlaxoSmithKline RD, Uxbridge, Middlesex, United KingdomKourtney Davis1Respiratory Epidemiology, GlaxoSmithKline RD, Uxbridge, Middlesex, United Kingdom
- Characteristics of patients newly prescribed a long acting bronchodilator in the United Kingdom (UK)By Sarah Landis, Keele Wurst, Hoa Le, Hana Muellerova and Kourtney DavisSarah Landis1Worldwide Epidemiology, GlaxoSmithKline, Uxbridge, United KingdomKeele Wurst2Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, NC,Hoa Le2Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, NC,Hana Muellerova1Worldwide Epidemiology, GlaxoSmithKline, Uxbridge, United KingdomKourtney Davis3Worldwide Epidemiology, GlaxoSmithKline, Wavre, Belgium
- COPD and risk of cardiovascular disease: A prospective study of 0.5M Chinese adultsBy Om Kurmi, Liming Li, Kourtney Davis, Jenny Wang, Ling Yang, Yiping Chen, Yu Guo, Zheng Bian, Rory Collins, Richard Peto and Zhengming ChenOm Kurmi1Nuffield Department of Population Health, University of Oxford, Oxford, United KingdomLiming Li2Department of Epidemiology and Biostatistics, Peking University, Beijing, China3National Co-ordinating Centre (China Kadoorie Biobank), National Academy of Medical Sciences, Beijing, ChinaKourtney Davis4Worldwide Epidemiology, GlaxoSmithKline R&D, Uxbridge, United KingdomJenny Wang1Nuffield Department of Population Health, University of Oxford, Oxford, United KingdomLing Yang1Nuffield Department of Population Health, University of Oxford, Oxford, United KingdomYiping Chen1Nuffield Department of Population Health, University of Oxford, Oxford, United KingdomYu Guo3National Co-ordinating Centre (China Kadoorie Biobank), National Academy of Medical Sciences, Beijing, ChinaZheng Bian3National Co-ordinating Centre (China Kadoorie Biobank), National Academy of Medical Sciences, Beijing, ChinaRory Collins1Nuffield Department of Population Health, University of Oxford, Oxford, United KingdomRichard Peto1Nuffield Department of Population Health, University of Oxford, Oxford, United KingdomZhengming Chen1Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
- Risk of cardiovascular events following COPD hospitalisation: Findings from the China Kadoorie Biobank cohort studyBy Om Kurmi, Liming Li, Kourtney Davis, Jenny Wang, Ling Yang, Yiping Chen, Yu Guo, Zheng Bian, Rory Collins, Richard Peto and Zhengming ChenOm Kurmi1Nuffield Department of Population Health, University of Oxford, Oxford, United KingdomLiming Li2Department of Epidemiology and Biostatistics, Peking University, Beijing, China3National Co-ordinating Centre (China Kadoorie Biobank), Chinese Academy of Medical Sciences, Beijing, ChinaKourtney Davis4Worldwide Epidemiology, GlaxoSmithKline, Uxbridge, United KingdomJenny Wang1Nuffield Department of Population Health, University of Oxford, Oxford, United KingdomLing Yang1Nuffield Department of Population Health, University of Oxford, Oxford, United KingdomYiping Chen1Nuffield Department of Population Health, University of Oxford, Oxford, United KingdomYu Guo3National Co-ordinating Centre (China Kadoorie Biobank), Chinese Academy of Medical Sciences, Beijing, ChinaZheng Bian3National Co-ordinating Centre (China Kadoorie Biobank), Chinese Academy of Medical Sciences, Beijing, ChinaRory Collins1Nuffield Department of Population Health, University of Oxford, Oxford, United KingdomRichard Peto1Nuffield Department of Population Health, University of Oxford, Oxford, United KingdomZhengming Chen1Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
- The burden of non-communicable lung disease in urban MalawiBy Kevin Mortimer, Hadia Azhar, Jaymini Patel, Sabrina Kapur, Louisa Gnatiuc, Peter Burney, Kourtney Davis, Gilbert Nadeau, Moffat Nyirenda and Stephen GordonKevin Mortimer1Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United KingdomHadia Azhar2National Heart and Lung Institute, Imperial College, London, United KingdomJaymini Patel2National Heart and Lung Institute, Imperial College, London, United KingdomSabrina Kapur2National Heart and Lung Institute, Imperial College, London, United KingdomLouisa Gnatiuc2National Heart and Lung Institute, Imperial College, London, United KingdomPeter Burney2National Heart and Lung Institute, Imperial College, London, United KingdomKourtney Davis3Worldwide Epidemiology, GSK, Wavre, BelgiumGilbert Nadeau3Worldwide Epidemiology, GSK, Wavre, BelgiumMoffat Nyirenda4Malawi Epidemiology and Intervention Research Unit, London School of Hygiene and Tropical Medicine, London, United KingdomStephen Gordon2National Heart and Lung Institute, Imperial College, London, United Kingdom
- Validation of the recording of acute exacerbations of COPD in the clinical practice research datalink: Phase 1 resultsBy Kieran Rothnie, Hana Mullerova, John Hurst, Liam Smeeth, Kourtney Davis, Sara Thomas and Jennifer QuintKieran Rothnie1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United KingdomHana Mullerova2Respiratory Epidemiology, GlaxoSmithKline R&D, Uxbridge, United KingdomJohn Hurst3UCL Respiratory Medicine, University College London Medical School, London, United KingdomLiam Smeeth1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United KingdomKourtney Davis2Respiratory Epidemiology, GlaxoSmithKline R&D, Uxbridge, United KingdomSara Thomas1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United KingdomJennifer Quint1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.